BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $855,000 | -39.5% | 7,208 | -29.8% | 0.27% | -38.5% |
| Q4 2021 | $1,414,000 | +1.4% | 10,265 | +2.2% | 0.44% | -12.0% |
| Q3 2021 | $1,394,000 | +13.8% | 10,046 | -20.4% | 0.50% | +13.9% |
| Q2 2021 | $1,225,000 | +40.8% | 12,621 | -0.8% | 0.44% | +27.2% |
| Q1 2021 | $870,000 | -21.3% | 12,726 | -1.3% | 0.35% | -24.8% |
| Q4 2020 | $1,105,000 | +33.9% | 12,889 | +1.6% | 0.46% | +18.9% |
| Q3 2020 | $825,000 | -10.0% | 12,692 | +1.2% | 0.39% | -21.7% |
| Q2 2020 | $917,000 | +324.5% | 12,542 | +97.4% | 0.49% | +229.3% |
| Q1 2020 | $216,000 | – | 6,352 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |